These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 19079439

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?
    Kerr AJ, Broad J, Wells S, Riddell T, Jackson R.
    Heart; 2009 Feb; 95(2):125-9. PubMed ID: 18381374
    [Abstract] [Full Text] [Related]

  • 23. Beyond hypertension toward guidelines for cardiovascular risk reduction.
    Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM.
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736
    [Abstract] [Full Text] [Related]

  • 24. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S, Wells S, Grey C, Riddell T, Kerr A, Marshall R, Ameratunga S, Harrison J, Kenealy T, Bramley D, Chan WC, Thornley S, Sundborn G, Jackson R.
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [Abstract] [Full Text] [Related]

  • 25. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
    Hanon O, Hoguin JC, Girerd X.
    Arch Mal Coeur Vaiss; 2003 Feb; 96(7-8):744-7. PubMed ID: 12945215
    [Abstract] [Full Text] [Related]

  • 26. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
    Mehta S, Wells S, Riddell T, Kerr A, Pylypchuk R, Marshall R, Ameratunga S, Chan WC, Thornley S, Crengle S, Harrison J, Drury P, Elley CR, Bell F, Jackson R.
    J Prim Health Care; 2011 Jun 01; 3(2):93-101. PubMed ID: 21625656
    [Abstract] [Full Text] [Related]

  • 27. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.
    Qin X, Jackson R, Marshall R, Lee L, Cao W, Zhan S, Hu Y.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb 01; 16(1):96-101. PubMed ID: 19237999
    [Abstract] [Full Text] [Related]

  • 28. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC, Atkins R.
    Intern Med J; 2009 Mar 01; 39(3):143-9. PubMed ID: 18771428
    [Abstract] [Full Text] [Related]

  • 29. [Initial management of hypertension in a primary care service].
    Nardo P, Bovier P, Pechère-Bertschi A.
    Rev Med Suisse; 2006 Sep 13; 2(78):2024-6, 2029-34. PubMed ID: 17019837
    [Abstract] [Full Text] [Related]

  • 30. Colchicine prescribing and safety monitoring in patients with gout.
    Ly J, Gow P, Dalbeth N.
    N Z Med J; 2007 Nov 09; 120(1265):U2808. PubMed ID: 18264188
    [Abstract] [Full Text] [Related]

  • 31. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.
    Emberson J, Whincup P, Morris R, Walker M, Ebrahim S.
    Eur Heart J; 2004 Mar 09; 25(6):484-91. PubMed ID: 15039128
    [Abstract] [Full Text] [Related]

  • 32. Preventing cardiovascular disease in women.
    Hayes SN.
    Am Fam Physician; 2006 Oct 15; 74(8):1331-40. PubMed ID: 17087427
    [Abstract] [Full Text] [Related]

  • 33. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O.
    J Hum Hypertens; 2009 Nov 15; 23(11):758-63. PubMed ID: 19242492
    [Abstract] [Full Text] [Related]

  • 34. Are all the hypertensives made equal?
    Flaa A, Kjeldsen SE.
    Herz; 2006 Jun 15; 31(4):323-30. PubMed ID: 16810472
    [Abstract] [Full Text] [Related]

  • 35. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I, Hamilton G, Humphrey A, Scragg A.
    N Z Med J; 2007 Sep 07; 120(1261):U2714. PubMed ID: 17853935
    [Abstract] [Full Text] [Related]

  • 36. [Continuing care of patients with cardiovascular risk in general practice: patients with hypertension and their care].
    Jancsó Z, Márton H, Simay A, Kovács E, Iléys I.
    Orv Hetil; 2006 Feb 26; 147(8):339-44. PubMed ID: 16579332
    [Abstract] [Full Text] [Related]

  • 37. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus.
    O'Neill SG, Pego-Reigosa JM, Hingorani AD, Bessant R, Isenberg DA, Rahman A.
    Rheumatology (Oxford); 2009 May 26; 48(5):573-5. PubMed ID: 19273540
    [Abstract] [Full Text] [Related]

  • 38. Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients.
    Haskell WL, Berra K, Arias E, Christopherson D, Clark A, George J, Hyde S, Klieman L, Myll J.
    Am J Cardiol; 2006 Dec 01; 98(11):1472-9. PubMed ID: 17126653
    [Abstract] [Full Text] [Related]

  • 39. Gaps in primary care documentation of cardiovascular risk factors.
    Rafter N, Wells S, Stewart A, Selak V, Whittaker R, Bramley D, Roseman P, Furness S, Jackson RT.
    N Z Med J; 2008 Feb 15; 121(1269):24-33. PubMed ID: 18278079
    [Abstract] [Full Text] [Related]

  • 40. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec 15; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.